Pub. Date : 1987 Mar
PMID : 3106456
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | 6-Hydroxydopamine (6-OHDA) pretreatment resulted in the degeneration of noradrenergic axon terminals containing PGP 9.5, tyrosine hydroxylase (TH) and neuropeptide tyrosine (NPY) immunoreactivities. | Oxidopamine | pro-neuropeptide Y | Cavia porcellus |
2 | 6-Hydroxydopamine (6-OHDA) pretreatment resulted in the degeneration of noradrenergic axon terminals containing PGP 9.5, tyrosine hydroxylase (TH) and neuropeptide tyrosine (NPY) immunoreactivities. | Oxidopamine | pro-neuropeptide Y | Cavia porcellus |
3 | 6-Hydroxydopamine (6-OHDA) pretreatment resulted in the degeneration of noradrenergic axon terminals containing PGP 9.5, tyrosine hydroxylase (TH) and neuropeptide tyrosine (NPY) immunoreactivities. | Oxidopamine | pro-neuropeptide Y | Cavia porcellus |
4 | 6-Hydroxydopamine (6-OHDA) pretreatment resulted in the degeneration of noradrenergic axon terminals containing PGP 9.5, tyrosine hydroxylase (TH) and neuropeptide tyrosine (NPY) immunoreactivities. | Oxidopamine | pro-neuropeptide Y | Cavia porcellus |